Loading...
Market
First country to implement stricter genetic risk disclosure in drug trials by Dec 31, 2025?
2
Resolution / Starting Odds
United States • 25%
United Kingdom • 25%
Canada • 25%
Other • 25%
Government announcements or official regulatory updates
Story
Alzheimer's Drugmakers Withheld Genetic Risk Information from Trial Participants and Families
Oct 24, 2024, 01:44 AM
Alzheimer's drugmakers did not inform trial participants and their families that genetic tests showed they were at high risk for brain bleeds. Participants were required to sign consent forms acknowledging the risk of brain injuries due to certain genetic profiles and that they would be tested, but the results were not disclosed to them. This has raised ethical concerns and questions about the role of private-equity backed IRB boards in the trials. One observer noted, 'It’s not even a matter of ethics, it’s a matter of common sense.'
View original story
Similar markets
Brazil • 25%
USA • 25%
UK • 25%
Other country • 25%
Iceland • 25%
United States • 25%
United Kingdom • 25%
Other • 25%
USA • 25%
EU • 25%
China • 25%
Other • 25%
United States • 25%
United Kingdom • 25%
Germany • 25%
Other • 25%
United States • 25%
China • 25%
United Kingdom • 25%
Other • 25%
United States • 33%
Mexico • 33%
Both Simultaneously • 34%
European Union • 25%
China • 25%
India • 25%
Other • 25%
United States • 25%
China • 25%
European Union • 25%
Other • 25%
United States • 25%
European Union • 25%
United Kingdom • 25%
Other • 25%
Canada • 25%
Australia • 25%
Germany • 25%
Other • 25%
United States • 25%
Canada • 25%
Both simultaneously • 25%
Neither • 25%
Australia • 25%
Canada • 25%
Any European Country • 25%
Other • 25%